Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clonidine
Drug ID BADD_D00502
Description Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors.[A180559] This activity is useful for the treatment of hypertension, severe pain, and ADHD.[L7237,L7240,L7243,L7246] Clonidine was granted FDA approval on 3 September 1974.[L7237]
Indications and Usage May be used as an adjunct in the treatment of hypertension, as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone, for differential diagnosis of pheochromocytoma in hypertensive patients, prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD).
Marketing Status Prescription; Discontinued
ATC Code C02AC01; N02CX02; S01EA04
DrugBank ID DB00575
KEGG ID D00281
MeSH ID D003000
PubChem ID 2803
TTD Drug ID D03SKR
NDC Product Code 69988-0033; 0597-0033; 51862-453; 50742-247; 51862-455; 0591-3508; 0591-3509; 0597-0032; 0378-0872; 0597-0031; 82089-102; 0378-0873; 0378-0871; 51862-454; 82089-103; 46708-830; 82089-101; 71511-503; 39822-2010; 39822-2000; 0591-3510; 69238-1426
Synonyms Clonidine | Klofenil | Clofenil | Chlophazolin | Clonidine Dihydrochloride | Dihydrochloride, Clonidine | Clonidine Hydrochloride | Hydrochloride, Clonidine | Clonidine Monohydrochloride | Monohydrochloride, Clonidine | Clonidine Monohydrobromide | Monohydrobromide, Clonidine | ST-155 | ST 155 | ST155 | Gemiton | Hemiton | Isoglaucon | Klofelin | Clofelin | Clopheline | M-5041T | M 5041T | M5041T | Catapres | Catapresan | Catapressan | Dixarit
Chemical Information
Molecular Formula C9H9Cl2N3
CAS Registry Number 4205-90-7
SMILES C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Abnormal dreams17.15.02.001; 19.02.03.001--Not Available
Accommodation disorder06.02.04.001--Not Available
Affective disorder19.04.04.0010.000206%Not Available
Aggression19.05.01.0010.000514%Not Available
Agitation17.02.05.012; 19.06.02.0010.000206%
Alcohol intolerance14.02.01.001--
Alopecia23.02.02.001--
Angioedema10.01.05.009; 23.04.01.001--Not Available
Anxiety19.06.02.002--
Apnoea22.02.01.0010.000308%
Application site erythema08.02.01.001; 12.07.01.001; 23.03.06.005--Not Available
Application site pain08.02.01.004; 12.07.01.004--Not Available
Application site rash08.02.01.016; 12.07.01.016; 23.03.13.008--Not Available
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Atrioventricular block02.03.01.002--Not Available
Atrioventricular block complete02.03.01.003--
Atrioventricular block first degree02.03.01.0040.000206%
Attention deficit/hyperactivity disorder19.21.04.0010.000206%Not Available
Autonomic nervous system imbalance08.01.01.010; 17.05.01.011; 24.06.01.0050.000054%Not Available
Back pain15.03.04.0050.000308%
Blood creatine phosphokinase increased13.04.01.001--
Blood glucose increased13.02.02.002--Not Available
Blood pressure increased13.14.03.0050.000822%Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.0020.001541%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene